🇺🇸 FDA
Pipeline program

Insulin Degludec and Insulin Aspart

22011-DM-301

Phase 3 small_molecule completed

Quick answer

Insulin Degludec and Insulin Aspart for Diabetes is a Phase 3 program (small_molecule) at Sunshine Biopharma with 1 ClinicalTrials.gov record(s).

Program details

Company
Sunshine Biopharma
Indication
Diabetes
Phase
Phase 3
Modality
small_molecule
Status
completed

Clinical trials